|
痰瘀互结证高血压研究热点与趋势的可视化分析
|
Abstract:
目的:系统梳理2003~2023年高血压痰瘀互结证领域的研究动态及前沿热点,揭示其学术发展脉络。方法:以中国知网(CNKI)、万方(Wanfang)、维普(VIP)数据库中2003年1月1日至2023年12月31日收录的高血压痰瘀互结证相关文献为研究对象,通过文献计量学方法对符合纳入标准的355篇文献进行定量分析,运用可视化技术对发文量时序分布、作者合作网络、机构协作关系及关键词共现网络进行图谱解析。结果:1) 年度发文量呈阶梯式增长,2010年后进入快速发展期(年均增长率达15.6%);2) 研究力量分布呈现核心作者引领与机构间协作不足的双重特征:韩学杰团队(累计发文23篇)及中国中医科学院中医临床基础医学研究所(发文量占比18.3%)为领域内主要贡献者,但73.5%的作者为独立发文,跨机构合作率不足10%;3) 关键词聚类分析显示,研究热点聚焦于四大主题:痰瘀互结证病理机制(如血脂异常、一氧化氮/内皮素失衡)、中医干预策略(化痰祛瘀复方、针药并用)、临床疗效评价(证候积分改善率)及生物标志物探索(炎症因子CRP、TNF-α)。结论:我国学者在高血压痰瘀互结证领域开展了积极且富有成效的研究,整体发展态势良好,研究广度和深度持续拓展。然而,目前的研究多集中于基础理论和临床实践层面,建议未来进一步深入分子水平和细胞机制的研究,并加强多机构间的合作与交流,以推动该领域的创新发展。
Objective: To systematically analyze the research trends and hotspots in the field of hypertension with phlegm and stasis interconnection from 2003 to 2023, and to reveal its academic development. Methods: Taking the literature related to hypertension phlegm and stasis syndrome included in the databases of China National Knowledge Infrastructure (CNKI), Wanfang and VIP from January 1, 2003 to December 31, 2023 as the research object, 355 pieces of literature meeting the inclusion criteria were quantitatively analyzed by bibliometric methods, and visualization techniques were used to analyze the temporal distribution of the number of articles, the authors’ collaborative network, Institutional Collaboration Network and Keyword Co-occurrence Network. Results: 1) The annual number of published papers increased step by step, and entered a period of rapid development after 2010 (with an average annual growth rate of 15.6%). 2) The distribution of research strength showed the dual characteristics of core author leadership and insufficient inter-agency collaboration: Han Xuejie’s team (23 articles in total) and the Institute of Clinical Basic Medicine of Chinese Academy of Chinese Medical Sciences (18.3 % of the total) were the main contributors in the field, but 73.5% of the authors were independent, and the cross-agency cooperation rate was less than 10%. 3) Keywords cluster analysis showed that the research hotspots focused on four major topics: the pathological mechanism of phlegm and blood stasis syndrome (such as dyslipidemia, nitric oxide/endothelin imbalance), TCM intervention strategies (Huatan Quyu compound, acupuncture and medicine), clinical efficacy evaluation (syndrome score improvement rate) and biomarker exploration (inflammatory factors CRP, TNF-α). Conclusion: Chinese
[1] | 修订委员会中国高血压防治指南. 中国高血压防治指南(2018年修订版) [J]. 中国心血管杂志, 2019, 24(1): 24-56. |
[2] | 中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2020概要[J]. 中国循环杂志, 2021, 36(6): 521-545. |
[3] | 贾晓雅, 劳闻文, 石立鹏, 等. 从痰瘀互结证论治原发性高血压病经验总结[J]. 实用中医药杂志, 2020, 36(2): 259-260. |
[4] | 陈悦, 陈超美, 刘则渊, 等. CiteSpace知识图谱的方法论功能[J]. 科学学研究, 2015, 33(2): 242-253. |
[5] | Chen, C. (2005) CiteSpace II: Detecting and Visualizing Emerging Trends and Transient Patterns in Scientific Literature. Journal of the American Society for Information Science and Technology, 57, 359-377. https://doi.org/10.1002/asi.20317 |
[6] | Chen, C. and Song, M. (2019) Visualizing a Field of Research: A Methodology of Systematic Scientometric Reviews. PLOS ONE, 14, e0223994. https://doi.org/10.1371/journal.pone.0223994 |
[7] | D.N赖斯, 赵红州, 蒋国华. 《小科学, 大科学》的由来与发展[J]. 科学学与科学技术管理, 1984(9): 15-16. |
[8] | Börner, K., Maru, J.T. and Goldstone, R.L. (2004) The Simultaneous Evolution of Author and Paper Networks. Proceedings of the National Academy of Sciences, 101, 5266-5273. https://doi.org/10.1073/pnas.0307625100 |
[9] | 袁润, 李莹, 王琦, 等. 用R语言分析关键词集共现网络研究[J]. 现代情报, 2018, 38(7): 88-94. |
[10] | 任艳莉. 我国机构知识库研究文献可视化分析研究[J]. 图书馆工作与研究, 2020(S1): 16-22. |
[11] | 施佺, 钱源. 大数据背景下教育领域热点问题研究——基于关键词共现分析[J]. 中国教育技术装备, 2016(18): 69-71. |
[12] | 高血压中医诊疗专家共识[J]. 中国实验方剂学杂志, 2019, 25(15): 217-221. |
[13] | 刘曼. 工商管理学科演进与前沿热点的可视化分析[J]. 营销界, 2020(12): 167-168. |
[14] | 王艳秋, 孟翔鹤, 秦静波, 等. 基于CiteSpace的中医药治疗过敏性紫癜可视化分析[J]. 中国实验方剂学杂志, 2020, 26(10): 173-179. |
[15] | 贾秋蕾, 石树青, 胡元会, 等. 基于CiteSpace的中药治疗心力衰竭知识图谱分析[J]. 中国循证心血管医学杂志, 2021, 13(1): 10-14. |
[16] | 陶紫晶, 独思静, 张格知, 等. 基于CiteSpace可视化分析中医药治疗胃食管反流病的研究热点与前沿[J]. 中医药导报, 2022, 28(3): 97-102. |
[17] | 沈稼轩, 宋渊, 梁旭东, 等. 2000-2021年中医药治疗糖尿病足溃疡文献可视化分析[J]. 中国中医药图书情报杂志, 2022, 46(5): 21-28. |
[18] | 李京, 张明雪, 肖蕾, 等. 200例高血压病患者中医体质与证候的相关性研究[J]. 中华中医药学刊, 2018, 36(12): 2907-2910. |
[19] | 邱志凌, 胡元会, 褚瑜光, 等. 基于数据挖掘的当代中医治疗痰瘀互结型高血压诊疗规律分析[J]. 中西医结合心脑血管病杂志, 2018, 16(4): 385-389. |
[20] | 张磊, 刘迎迎, 于杰, 等. 高血压痰瘀互结证证治源流及本质探析[J]. 世界中医药, 2021, 16(10): 1561-1566. |
[21] | 代爽, 何庆勇, 杨戈, 等. 基于对应分析探讨血脂异常患者中医证候与合并病的相关性[J]. 中华中医药杂志, 2022, 37(2): 1141-1144. |
[22] | 侯胜利, 王文峰, 刘楚言. 瑞舒伐他汀钙联合氨氯地平治疗高血压合并冠心病的疗效及对患者血管内皮功能的影响[J]. 右江医学, 2019, 47(4): 266-270. |
[23] | 许乐, 李立, 唐娜娜. 高血压的中医诊疗进展[J]. 江西中医药, 2024, 55(3): 74-77, 84. |